HK1202794A1 - 丙型肝炎病毒的免疫治療 - Google Patents

丙型肝炎病毒的免疫治療

Info

Publication number
HK1202794A1
HK1202794A1 HK14113158.5A HK14113158A HK1202794A1 HK 1202794 A1 HK1202794 A1 HK 1202794A1 HK 14113158 A HK14113158 A HK 14113158A HK 1202794 A1 HK1202794 A1 HK 1202794A1
Authority
HK
Hong Kong
Prior art keywords
hcv
immunotherapy
hcv immunotherapy
Prior art date
Application number
HK14113158.5A
Other languages
English (en)
Inventor
Michel Morre
Thrse Croughs
Stephanie Beq
Brigitte Assouline
Pierre Demol
Original Assignee
Cytheris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47628658&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1202794(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cytheris filed Critical Cytheris
Publication of HK1202794A1 publication Critical patent/HK1202794A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2046—IL-7
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK14113158.5A 2011-08-03 2014-12-11 丙型肝炎病毒的免疫治療 HK1202794A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11306012 2011-08-03
US201161514915P 2011-08-04 2011-08-04
PCT/EP2012/065125 WO2013017653A1 (en) 2011-08-03 2012-08-02 Hcv immunotherapy

Publications (1)

Publication Number Publication Date
HK1202794A1 true HK1202794A1 (zh) 2015-10-09

Family

ID=47628658

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14113158.5A HK1202794A1 (zh) 2011-08-03 2014-12-11 丙型肝炎病毒的免疫治療

Country Status (18)

Country Link
US (1) US20140377218A1 (zh)
EP (1) EP2739301B1 (zh)
JP (1) JP2014521679A (zh)
KR (1) KR20140063657A (zh)
CN (1) CN103917240A (zh)
AU (1) AU2012292032A1 (zh)
BR (1) BR112014002365A2 (zh)
CA (1) CA2843495A1 (zh)
CL (1) CL2014000269A1 (zh)
CR (1) CR20140101A (zh)
EA (1) EA201490399A1 (zh)
ES (1) ES2568755T3 (zh)
HK (1) HK1202794A1 (zh)
IL (1) IL230669A0 (zh)
MX (1) MX2014001355A (zh)
SG (1) SG10201606395XA (zh)
WO (1) WO2013017653A1 (zh)
ZA (1) ZA201401986B (zh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101873201B1 (ko) 2015-06-11 2018-07-02 주식회사 제넥신 변형된 인터루킨-7 단백질 및 이의 용도
KR102386735B1 (ko) 2015-11-06 2022-04-14 주식회사 제넥신 변형된 인터루킨-7 융합 단백질의 제형
KR20170066265A (ko) 2015-12-04 2017-06-14 주식회사 제넥신 면역글로불린 Fc가 융합된 인터루킨-7 융합 단백질을 포함하는 사람 파필로마바이러스 유래 질환의 예방 또는 치료용 약학적 조성물
KR102604595B1 (ko) 2015-12-04 2023-11-21 주식회사 제넥신 면역글로불린 Fc가 융합된 인터루킨-7 융합 단백질을 포함하는 인플루엔자 바이러스 감염의 예방 또는 치료용 약학적 조성물
US11096965B2 (en) 2016-04-04 2021-08-24 The Regents Of The University Of California Compositions and methods related to polycytotoxic T cells
JP2022547056A (ja) * 2019-09-04 2022-11-10 ジェネクシン・インコーポレイテッド 腫瘍においてｉｌ－７融合タンパク質を用いてリンパ球数を増加させる方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
ZA887773B (en) 1987-10-26 1989-07-26 Immunex Corp Interleukin-7
US5026687A (en) 1990-01-03 1991-06-25 The United States Of America As Represented By The Department Of Health And Human Services Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds
WO1994019012A2 (en) 1993-02-24 1994-09-01 Wang Jui H Compositions and methods of application of reactive antiviral polymers
CA2167537A1 (en) 1993-07-19 1995-02-02 Tsuneo Ozeki Hepatitis c virus proliferation inhibitor
DE4432623A1 (de) 1994-09-14 1996-03-21 Huels Chemische Werke Ag Verfahren zur Bleichung von wäßrigen Tensidlösungen
US5830905A (en) 1996-03-29 1998-11-03 Viropharma Incorporated Compounds, compositions and methods for treatment of hepatitis C
US5633388A (en) 1996-03-29 1997-05-27 Viropharma Incorporated Compounds, compositions and methods for treatment of hepatitis C
TW517067B (en) 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
US5891874A (en) 1996-06-05 1999-04-06 Eli Lilly And Company Anti-viral compound
US5922757A (en) 1996-09-30 1999-07-13 The Regents Of The University Of California Treatment and prevention of hepatic disorders
GB9623908D0 (en) 1996-11-18 1997-01-08 Hoffmann La Roche Amino acid derivatives
EA002254B1 (ru) 1997-06-30 2002-02-28 Мерц + Ко. Гмбх Унд Ко. 1-аминоалкилциклогексановые антагонисты рецепторов nmda
EP1391513A1 (en) 2002-08-08 2004-02-25 Cytheris IL-7 drug substance, IL-7 comprising composition, preparation and uses thereof
EP1699822B1 (en) 2003-12-30 2008-04-23 MERCK PATENT GmbH Il-7 fusion proteins with antibody portions, their preparation and their use
BRPI0519000A2 (pt) 2004-12-09 2008-12-23 Merck Patent Gmbh variantes de il-7 com imunogenicidade reduzida
EP1746161A1 (en) 2005-07-20 2007-01-24 Cytheris Glycosylated IL-7, preparation and uses
CN101152567A (zh) * 2006-09-29 2008-04-02 上海新生源医药研究有限公司 重组人白介素-11的药物组合
JP2013500713A (ja) 2009-07-31 2013-01-10 サントル オスピタリエ ウニヴェルシテール ヴォドア Ｈｃｖ感染患者においてｃ型肝炎の転帰を診断又は予測する方法

Also Published As

Publication number Publication date
JP2014521679A (ja) 2014-08-28
CN103917240A (zh) 2014-07-09
WO2013017653A1 (en) 2013-02-07
EP2739301A1 (en) 2014-06-11
ES2568755T3 (es) 2016-05-04
CA2843495A1 (en) 2013-02-07
NZ620689A (en) 2016-03-31
IL230669A0 (en) 2014-03-31
SG10201606395XA (en) 2016-09-29
US20140377218A1 (en) 2014-12-25
CR20140101A (es) 2014-05-26
KR20140063657A (ko) 2014-05-27
MX2014001355A (es) 2014-11-21
AU2012292032A1 (en) 2014-03-13
BR112014002365A2 (pt) 2017-02-21
EA201490399A1 (ru) 2014-06-30
ZA201401986B (en) 2015-07-29
EP2739301B1 (en) 2016-01-20
CL2014000269A1 (es) 2014-10-10

Similar Documents

Publication Publication Date Title
DK3424953T3 (en) Terapeutiske antistoffer
HK1195016A1 (zh) 蛋白質-聚合物-藥物共軛物
GB201204966D0 (en) Djml
EP2673635A4 (en) IMMUNOTHERAPY THROUGH APOE
EP2723631A4 (en) QUADFOILER
IL266981A (en) Preparation for colonoscopy
ZA201309148B (en) Mosaic piece
EP2748843A4 (en) susceptor
EP2663331A4 (en) NEW USES
HK1202794A1 (zh) 丙型肝炎病毒的免疫治療
GB201115910D0 (en) Peptides
GB201301300D0 (en) No details
GB201119167D0 (en) Novel bachteriophages
HK1187628A1 (zh) 新型肽
EP2714717A4 (en) PHOENIXINPEPTIDE
GB201111219D0 (en) Sequence
GB201111218D0 (en) Sequence
GB201107854D0 (en) Novel 5-hydroxy-5-aryl-pyrrol-2-ones
GB201104514D0 (en) Re-directed immunotherapy
GB201303586D0 (en) No details
GB201113206D0 (en) Novel uses
GB201115014D0 (en) Peptides
GB201110793D0 (en) Easy carry
GB201109631D0 (en) Better picniks
GB201115167D0 (en) No details

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20200729